Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Predicting Sustained Benefit From Tirzepatide in SURPASS-4: Who Benefits and Why? | Pepdox

Home
Search
PMID 40971612

Predicting Sustained Benefit From Tirzepatide in SURPASS-4: Who Benefits and Why?

Diabetes2025PMID: 40971612

View on PubMed DOI: 10.2337/dbi25-0033

Authors

Varadinova, Miroslava; Wagner, Robert